NCT00977444View on ClinicalTrials.gov

Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

October 31, 2009

Conditions
Osteoarthritis
Interventions
DRUG

kondrium

intraarticular injections once month

DRUG

kondrium f

intraarticular injections once month

DRUG

methyl prednisolone (corticosteroid)

intraarticular injections once month

Trial Locations (1)

Unknown

Hospital San Jose, Querétaro City

Sponsors

Lead Sponsor

Nucitec
All Listed Sponsors
collaborator

National Council of Science and Technology, Mexico

OTHER

lead

Nucitec

INDUSTRY

NCT00977444 - Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment | Biotech Hunter | Biotech Hunter